Nuzenio

Recursion Pharmaceuticals

Recursion Pharmaceuticals news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 24 latest news signals 13 publisher sources 100/100 entity strength

Latest news

Timeline

Sat, 08 Aug 2026 14:45:00 GMTAbCellera (NASDAQ:ABCL) Shares Surge Ahead of Monday's ABCL635 Phase 2 Trial Results - TechStock²
Sat, 08 Aug 2026 06:29:09 GMTRecursion Pharmaceuticals (NASDAQ:RXRX) Cut to "Strong Sell" at Wall Street Zen - MarketBeat
Sat, 08 Aug 2026 05:45:46 GMTRecursion Pharmaceuticals (RXRX) Reported Q2 Revenue Pressure, Is The Valuation Gap Too Wide? - simplywall.st
Sat, 08 Aug 2026 00:33:02 GMTRecursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144 - Moomoo
Fri, 07 Aug 2026 15:03:51 GMTRecursion Pharmaceuticals Inc (RXRX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Fri, 07 Aug 2026 14:49:17 GMTRecursion Pharmaceuticals | SCHEDULE 13G: Others - Moomoo

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Recursion Pharmaceuticals.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

13 distinct publisher/source names are currently connected to this entity page.